These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant. Hergüner MO; Tepe T; Altunbaşak S; Baytok V Turk J Pediatr; 2008; 50(1):91-3. PubMed ID: 18365602 [TBL] [Abstract][Full Text] [Related]
74. Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome? Godoy DA; Rabinstein A Arq Neuropsiquiatr; 2015 Oct; 73(10):848-51. PubMed ID: 26465402 [TBL] [Abstract][Full Text] [Related]
75. Miller Fisher variant of Guillain-Barré syndrome masquerading as acute sphenoid sinusitis with orbital apex syndrome. Chaudhary A; Ramchand T; Frohman LP; Liu JK; Eloy JA Laryngoscope; 2012 May; 122(5):970-2. PubMed ID: 22447677 [TBL] [Abstract][Full Text] [Related]
76. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102 [TBL] [Abstract][Full Text] [Related]
77. Multiple complications of IVIG therapy in a patient with Guillain-Barré syndrome. Steinberger B; Coleman TA Am J Hematol; 2001 May; 67(1):59. PubMed ID: 11279662 [No Abstract] [Full Text] [Related]
78. Is a second course of intravenous immunoglobulin treatment in Guillain-Barré syndrome justifiable? Yang J; Jia R J Clin Neurosci; 2020 Jul; 77():251-252. PubMed ID: 32362471 [No Abstract] [Full Text] [Related]